Tag: drug-eluting stents
Without additional long-term and patient-level data, Katsanos et al’s conclusion is premature
By Thomas Zeller
The Katsanos et al meta-analysis reports an increased risk of mortality beyo...
Third-generation drug-eluting stents and beyond: Where were we, where are we, and where we are heading
Second-generation drug-eluting stents resolved the issues of late and very late stent thrombosis...
NORSTENT shows bare metal stents have improved
The NORSTENT (Norwegian coronary stent trial) study, which was presented at the 2016 European So...
ESC 2016: Bare metal stents inferior to drug-eluting stents for saphenous vein graft PCI at three years
Data from a new study, BASKET-SAVAGE, indicate that patients who receive a drug-eluting stent wh...
ESC 2016: Drug-eluting stents are still preferred despite no long-term survival advantage over bare metal stents
The results of NORSTENT (Norwegian coronary stent trial) indicate that second-generation drug-el...
